These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19875567)

  • 1. Hypertension and diabetes: should we treat early surrogates? What are the cons?
    Nilsson PM
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S290-3. PubMed ID: 19875567
    [No Abstract]   [Full Text] [Related]  

  • 2. When to treat the hypertensive diabetic patient.
    Fuller JH
    J Diabetes Complications; 1996; 10(3):144-5. PubMed ID: 8807461
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension and diabetes and the Fosinopril versus Amlodipine Cardiovascular Events Trial (FACET). More ammunition against surrogate end points.
    Califf RM; Granger CB
    Diabetes Care; 1998 Apr; 21(4):655-7. PubMed ID: 9571359
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypertension therapy for type 2 diabetics].
    Bönner G
    MMW Fortschr Med; 2007 Jun; 149(23):45, 47-8. PubMed ID: 18062579
    [No Abstract]   [Full Text] [Related]  

  • 5. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack (ALLHAT) Trial: focus on the diabetic patient.
    Berecek KH; Farag A; Bahtiyar G; Rothman J; McFarlane SI
    Curr Hypertens Rep; 2004 Jun; 6(3):212-4. PubMed ID: 15128474
    [No Abstract]   [Full Text] [Related]  

  • 6. CCBs vs ACE inhibitors in patients with diabetes.
    Zamorski MA
    J Fam Pract; 1998 Jul; 47(1):12-3. PubMed ID: 9673598
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypertension and Diabetes: what are the pros to treating early surrogates?
    Schmieder RE
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S294-7. PubMed ID: 19875568
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiproteinuric effects of combined antihypertensive therapies in patients with overt type 2 diabetic nephropathy.
    Kuriyama S; Tomonari H; Tokudome G; Horiguchi M; Hayashi H; Kobayashi H; Ishikawa M; Hosoya T
    Hypertens Res; 2002 Nov; 25(6):849-55. PubMed ID: 12484508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].
    Nilsson PM
    Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive treatment and mortality in diabetic patients. What is the evidence?
    Sawicki PT; Heise T; Berger M
    Diabetologia; 1997 Jul; 40 Suppl 2():S134-7. PubMed ID: 9248721
    [No Abstract]   [Full Text] [Related]  

  • 11. High blood pressure and diabetes mellitus: are all antihypertensive drugs created equal?
    Grossman E; Messerli FH; Goldbourt U
    Arch Intern Med; 2000 Sep; 160(16):2447-52. PubMed ID: 10979055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin blockade in type 2 diabetes: what the new evidence tells us about renal and cardiac complications.
    Studney D
    Can J Cardiol; 2002 May; 18 Suppl A():3A-6A. PubMed ID: 12045787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.
    Berl T; Hunsicker LG; Lewis JB; Pfeffer MA; Porush JG; Rouleau JL; Drury PL; Esmatjes E; Hricik D; Parikh CR; Raz I; Vanhille P; Wiegmann TB; Wolfe BM; Locatelli F; Goldhaber SZ; Lewis EJ;
    Ann Intern Med; 2003 Apr; 138(7):542-9. PubMed ID: 12667024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of ACE inhibitors on diabetic patients without renal disease.
    Kirpichnikov D; Winer N; Sowers JR
    Curr Diab Rep; 2002 Feb; 2(1):21-5. PubMed ID: 12643119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure control in type 2 diabetes mellitus.
    Krantz MJ
    Ann Intern Med; 2004 Mar; 140(6):487; author reply 487-8. PubMed ID: 15023718
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Overview of cardiovascular risk factors].
    De la Figuera von Wichmann M; Llisterri Caro JL
    Med Clin (Barc); 2006 Nov; 127(20):774-5. PubMed ID: 17198664
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antihypertensive drug therapy in diabetes mellitus].
    Ratzmann KP
    Z Arztl Fortbild (Jena); 1990; 84(21):1109-10. PubMed ID: 1980768
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.
    Pahor M; Psaty BM; Alderman MH; Applegate WB; Williamson JD; Furberg CD
    Diabetes Care; 2000 Jul; 23(7):888-92. PubMed ID: 10895836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
    Jamerson K; Weber MA; Bakris GL; Dahlöf B; Pitt B; Shi V; Hester A; Gupte J; Gatlin M; Velazquez EJ;
    N Engl J Med; 2008 Dec; 359(23):2417-28. PubMed ID: 19052124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.